Financial Ratios Aier Eye Hospital Group Co., Ltd.
Equities
300015
CNE100000GR6
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.40 CNY | +0.88% |
|
-1.47% | -13.96% |
| 11-28 | Aier Eye Hospital Group Co., Ltd. Approves Interim Dividend of Year 2025 | CI |
| 11-28 | Aier Eye Hospital Group Co., Ltd. Appoints Liu Duan and Tian Suhua as Independent Director | CI |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 15.04 | 13.45 | 10.03 | 11.5 | 8.78 | |||||
Return on Total Capital | 18.52 | 16.64 | 12.19 | 13.66 | 10.27 | |||||
Return On Equity % | 21.24 | 21.59 | 18.02 | 19.43 | 17.86 | |||||
Return on Common Equity | 20.96 | 21.96 | 18.04 | 18.91 | 17.97 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 51.02 | 51.92 | 50.46 | 50.79 | 48.12 | |||||
SG&A Margin | 20.93 | 22.71 | 23.9 | 22.77 | 24.51 | |||||
EBITDA Margin % | 31.06 | 29.98 | 27.88 | 28.92 | 25.14 | |||||
EBITA Margin % | 27.71 | 26.83 | 24.26 | 25.69 | 21.31 | |||||
EBIT Margin % | 27.7 | 26.81 | 24.13 | 25.64 | 21.23 | |||||
Income From Continuing Operations Margin % | 15.76 | 16.47 | 16.69 | 17.95 | 17.81 | |||||
Net Income Margin % | 14.47 | 15.49 | 15.67 | 16.49 | 16.95 | |||||
Net Avail. For Common Margin % | 14.47 | 15.49 | 15.67 | 16.49 | 16.95 | |||||
Normalized Net Income Margin | 16.37 | 15.92 | 14.23 | 14.47 | 12.42 | |||||
Levered Free Cash Flow Margin | 16.16 | 20.3 | 16.2 | 15.26 | 12.3 | |||||
Unlevered Free Cash Flow Margin | 16.55 | 20.99 | 16.89 | 15.85 | 13.06 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.87 | 0.8 | 0.67 | 0.72 | 0.66 | |||||
Fixed Assets Turnover | 4.88 | 3.22 | 2.28 | 2.45 | 2.17 | |||||
Receivables Turnover (Average Receivables) | 9.17 | 10.21 | 10.37 | 11.67 | 10.74 | |||||
Inventory Turnover (Average Inventory) | 13.43 | 13.53 | 12.26 | 12.29 | 11.55 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.69 | 1.15 | 1.8 | 1.69 | 1.45 | |||||
Quick Ratio | 1.49 | 1.03 | 1.62 | 1.51 | 1.26 | |||||
Operating Cash Flow to Current Liabilities | 1 | 0.65 | 0.84 | 0.98 | 0.73 | |||||
Days Sales Outstanding (Average Receivables) | 39.93 | 35.74 | 35.19 | 31.29 | 34.06 | |||||
Days Outstanding Inventory (Average Inventory) | 27.25 | 26.97 | 29.78 | 29.69 | 31.69 | |||||
Average Days Payable Outstanding | 78.22 | 70.95 | 63.8 | 59.77 | 65.25 | |||||
Cash Conversion Cycle (Average Days) | -11.05 | -8.24 | 1.18 | 1.21 | 0.51 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 19.53 | 44.79 | 25.86 | 27.97 | 31.08 | |||||
Total Debt / Total Capital | 16.34 | 30.94 | 20.55 | 21.85 | 23.71 | |||||
LT Debt/Equity | 12.97 | 25.81 | 19.55 | 19.88 | 20.93 | |||||
Long-Term Debt / Total Capital | 10.85 | 17.82 | 15.53 | 15.54 | 15.97 | |||||
Total Liabilities / Total Assets | 31.46 | 44.05 | 33.72 | 33.66 | 34.41 | |||||
EBIT / Interest Expense | 43.78 | 24.43 | 21.88 | 26.81 | 17.43 | |||||
EBITDA / Interest Expense | 49.08 | 30.12 | 28.36 | 33.62 | 23.57 | |||||
(EBITDA - Capex) / Interest Expense | 37.22 | 21.05 | 20.54 | 26.13 | 16.41 | |||||
Total Debt / EBITDA | 0.56 | 1.1 | 0.9 | 0.85 | 1.13 | |||||
Net Debt / EBITDA | -0.35 | 0.16 | -0.47 | -0.2 | 0.11 | |||||
Total Debt / (EBITDA - Capex) | 0.74 | 1.58 | 1.25 | 1.1 | 1.62 | |||||
Net Debt / (EBITDA - Capex) | -0.46 | 0.22 | -0.64 | -0.26 | 0.16 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 19.24 | 25.93 | 7.39 | 26.43 | 3.02 | |||||
Gross Profit, 1 Yr. Growth % | 23.39 | 28.16 | 4.38 | 27.26 | -2.41 | |||||
EBITDA, 1 Yr. Growth % | 37.99 | 20.95 | -0.45 | 30.71 | -10.74 | |||||
EBITA, 1 Yr. Growth % | 41.09 | 21.27 | -3.25 | 33.4 | -14.89 | |||||
EBIT, 1 Yr. Growth % | 41.72 | 21.79 | -3.36 | 34.38 | -14.7 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 31.16 | 31.58 | 8.87 | 35.96 | 2.19 | |||||
Net Income, 1 Yr. Growth % | 25.01 | 34.78 | 8.65 | 33.07 | 5.87 | |||||
Normalized Net Income, 1 Yr. Growth % | 36.51 | 22.36 | -3.99 | 28.6 | -11.59 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 23.29 | 32.82 | 9.39 | 30.33 | 5.95 | |||||
Accounts Receivable, 1 Yr. Growth % | 20.04 | 7.01 | 4.44 | 19.97 | 4.94 | |||||
Inventory, 1 Yr. Growth % | 32.16 | 15.52 | 27.94 | 23.08 | 9.54 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 29.83 | 137.51 | 15.99 | 18.81 | 13.75 | |||||
Total Assets, 1 Yr. Growth % | 30.65 | 40.59 | 21.65 | 13.57 | 10.17 | |||||
Tangible Book Value, 1 Yr. Growth % | 59.66 | 14.94 | 66.63 | 10.53 | -0.77 | |||||
Common Equity, 1 Yr. Growth % | 49.44 | 14.77 | 47.41 | 13.1 | 9.86 | |||||
Cash From Operations, 1 Yr. Growth % | 60.87 | 22.15 | 9.95 | 30.76 | -16.86 | |||||
Capital Expenditures, 1 Yr. Growth % | 19.86 | 67.18 | -7.08 | 5.15 | 25.37 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 22.84 | 42.53 | -14.28 | 19.02 | -16.95 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 22.48 | 44.17 | -13.55 | 18.64 | -15.14 | |||||
Dividend Per Share, 1 Yr. Growth % | 28.46 | 3.8 | 8.31 | 95.09 | 6.65 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 21.96 | 22.54 | 16.29 | 16.52 | 14.13 | |||||
Gross Profit, 2 Yr. CAGR % | 27.08 | 25.75 | 15.66 | 15.25 | 11.44 | |||||
EBITDA, 2 Yr. CAGR % | 37.98 | 29.51 | 9.9 | 14.27 | 8.2 | |||||
EBITA, 2 Yr. CAGR % | 39.17 | 31.17 | 8.51 | 13.82 | 6.76 | |||||
EBIT, 2 Yr. CAGR % | 40.14 | 31.42 | 8.49 | 13.96 | 7.06 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 32.71 | 31.37 | 19.69 | 21.66 | 17.87 | |||||
Net Income, 2 Yr. CAGR % | 30.71 | 29.8 | 21.01 | 20.24 | 18.69 | |||||
Normalized Net Income, 2 Yr. CAGR % | 48.35 | 29.29 | 8.39 | 11.12 | 6.63 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 29.84 | 27.97 | 20.54 | 18.96 | 17.51 | |||||
Accounts Receivable, 2 Yr. CAGR % | 26.69 | 13.34 | 5.72 | 11.94 | 12.2 | |||||
Inventory, 2 Yr. CAGR % | 17.36 | 23.56 | 21.58 | 25.49 | 16.11 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 28.63 | 75.6 | 65.98 | 17.39 | 16.25 | |||||
Total Assets, 2 Yr. CAGR % | 27.06 | 35.53 | 30.78 | 17.54 | 11.86 | |||||
Tangible Book Value, 2 Yr. CAGR % | 31.9 | 35.46 | 38.39 | 35.71 | 4.73 | |||||
Common Equity, 2 Yr. CAGR % | 31.56 | 30.96 | 30.07 | 29.12 | 11.47 | |||||
Cash From Operations, 2 Yr. CAGR % | 54.55 | 40.18 | 15.89 | 19.91 | 4.26 | |||||
Capital Expenditures, 2 Yr. CAGR % | 5 | 41.56 | 24.63 | -1.16 | 14.82 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 112.74 | 39.42 | 10.53 | 1.01 | -0.58 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 124.57 | 39.85 | 11.64 | 1.27 | 0.34 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.87 | 16.15 | 5.95 | 45.36 | 44.24 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 25.95 | 23.27 | 17.27 | 19.58 | 11.84 | |||||
Gross Profit, 3 Yr. CAGR % | 30.11 | 27.44 | 18.18 | 19.4 | 9.04 | |||||
EBITDA, 3 Yr. CAGR % | 42.14 | 32.27 | 18.76 | 16.57 | 5.36 | |||||
EBITA, 3 Yr. CAGR % | 43.97 | 33.18 | 18.66 | 16.39 | 3.44 | |||||
EBIT, 3 Yr. CAGR % | 44.59 | 33.76 | 18.62 | 16.51 | 3.47 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 33.29 | 32.33 | 23.4 | 24.88 | 14.79 | |||||
Net Income, 3 Yr. CAGR % | 32.41 | 32.05 | 22.33 | 24.9 | 15.24 | |||||
Normalized Net Income, 3 Yr. CAGR % | 50.05 | 39.16 | 17.08 | 14.75 | 2.96 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 30.62 | 30.82 | 21.45 | 23.41 | 14.45 | |||||
Accounts Receivable, 3 Yr. CAGR % | 40.22 | 19.76 | 10.3 | 10.27 | 9.55 | |||||
Inventory, 3 Yr. CAGR % | 21.78 | 16.75 | 25.01 | 22.07 | 19.93 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 29.97 | 57.8 | 52.93 | 48.47 | 16.17 | |||||
Total Assets, 3 Yr. CAGR % | 18.61 | 31.42 | 30.74 | 24.77 | 15.03 | |||||
Tangible Book Value, 3 Yr. CAGR % | 28.25 | 25.99 | 45.15 | 28.4 | 22.26 | |||||
Common Equity, 3 Yr. CAGR % | 23.62 | 25.71 | 36.23 | 24.15 | 22.35 | |||||
Cash From Operations, 3 Yr. CAGR % | 35.96 | 42.89 | 29.28 | 20.65 | 6.13 | |||||
Capital Expenditures, 3 Yr. CAGR % | 13.85 | 22.6 | 23.02 | 17.77 | 7 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 29.06 | 92.75 | 18.55 | 13.29 | -5.37 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 29.25 | 100.44 | 19.13 | 13.92 | -4.52 | |||||
Dividend Per Share, 3 Yr. CAGR % | 7.76 | 9.54 | 13.42 | 29.86 | 31.11 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 30.35 | 30.26 | 21.99 | 20.52 | 16 | |||||
Gross Profit, 5 Yr. CAGR % | 32.74 | 33.39 | 24.12 | 22.42 | 15.44 | |||||
EBITDA, 5 Yr. CAGR % | 39.13 | 40.3 | 28.37 | 24.83 | 14.5 | |||||
EBITA, 5 Yr. CAGR % | 41.2 | 42.45 | 28.72 | 25.16 | 13.83 | |||||
EBIT, 5 Yr. CAGR % | 41.26 | 42.52 | 28.91 | 25.46 | 13.86 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 33.87 | 34.24 | 27.67 | 27.96 | 21.16 | |||||
Net Income, 5 Yr. CAGR % | 32.13 | 33.06 | 27.73 | 27.19 | 20.86 | |||||
Normalized Net Income, 5 Yr. CAGR % | 39.67 | 41.04 | 31.76 | 27.18 | 12.78 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 30.22 | 31 | 26.49 | 25.94 | 19.68 | |||||
Accounts Receivable, 5 Yr. CAGR % | 46.13 | 39.8 | 25.24 | 16.57 | 11.05 | |||||
Inventory, 5 Yr. CAGR % | 23.17 | 22.54 | 21.7 | 20.17 | 21.37 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 30.52 | 51.82 | 43.33 | 40.19 | 37.04 | |||||
Total Assets, 5 Yr. CAGR % | 36.69 | 37.61 | 23.34 | 25.68 | 22.83 | |||||
Tangible Book Value, 5 Yr. CAGR % | 22.98 | 22.63 | 32.21 | 29.79 | 27.38 | |||||
Common Equity, 5 Yr. CAGR % | 32.69 | 29.94 | 26.16 | 27.06 | 25.73 | |||||
Cash From Operations, 5 Yr. CAGR % | 44.97 | 39.43 | 27.55 | 33.21 | 18.62 | |||||
Capital Expenditures, 5 Yr. CAGR % | 27.93 | 29.25 | 18.05 | 12.48 | 19.67 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 42.58 | 46.07 | 23.87 | 48.85 | 10.49 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 43.27 | 46.87 | 24.41 | 52.54 | 11.22 | |||||
Dividend Per Share, 5 Yr. CAGR % | 13.46 | 26.91 | 7.29 | 22.63 | 24.87 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















